121 related articles for article (PubMed ID: 7684950)
1. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.
Lee TC; Zhang Y; Aston C; Hintz R; Jagirdar J; Perle MA; Burt M; Rom WN
Cancer Res; 1993 Jun; 53(12):2858-64. PubMed ID: 7684950
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
[TBL] [Abstract][Full Text] [Related]
3. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
5. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
Hoang CD; Zhang X; Scott PD; Guillaume TJ; Maddaus MA; Yee D; Kratzke RA
Cancer Res; 2004 Oct; 64(20):7479-85. PubMed ID: 15492273
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
9. Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.
Yee D; Morales FR; Hamilton TC; Von Hoff DD
Cancer Res; 1991 Oct; 51(19):5107-12. PubMed ID: 1717138
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
Yee D; Jackson JG; Kozelsky TW; Figueroa JA
Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
[TBL] [Abstract][Full Text] [Related]
11. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
Bermont L; Fauconnet S; Lamielle F; Adessi GL
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
Brady G; Crean SJ; Naik P; Kapas S
Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of dihydrofolate reductase by bovine kidney epithelial cells results in altered cell morphology, IGF-I responsiveness, and IGF binding protein-3 expression.
Cohick WS; Clemmons DR
J Cell Physiol; 1994 Oct; 161(1):178-86. PubMed ID: 7523425
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork.
Wirtz MK; Xu H; Rust K; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):45-53. PubMed ID: 9430544
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
17. Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors.
Versnel MA; Claesson-Welsh L; Hammacher A; Bouts MJ; van der Kwast TH; Eriksson A; Willemsen R; Weima SM; Hoogsteden HC; Hagemeijer A
Oncogene; 1991 Nov; 6(11):2005-11. PubMed ID: 1658707
[TBL] [Abstract][Full Text] [Related]
18. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
20. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
